Standard Biotools Stock Pattern Recognition Thrusting Pattern
| LAB Stock | USD 0.93 -0.04 -4.12% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The Thrusting Pattern describes Standard Biotools bearish continuation trend.
Standard Biotools Technical Analysis Modules
Most technical analysis of Standard Biotools help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Standard from various momentum indicators to cycle indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California. Standard Biotools operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 615 people. The stock overview for Standard Biotools summarizes business drivers, financial profile, and market behavior. The company is positioned within Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 0.88, profit margin of -87.77%. Standard Biotools has a market cap of 357.84 M, ROE of -13.13%.
Methodology
Unless otherwise specified, financial data for Standard Biotools is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Standard (USA Stocks:LAB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Standard Biotools may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Standard Biotools in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Standard Biotools' short interest history, or implied volatility extrapolated from Standard Biotools options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Momentum Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Software Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Advertising Invested few shares | |
 | Cash Cows Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Picks Invested few shares |
More Resources for Standard Stock Analysis
A structured review of Standard Biotools often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Standard Biotools Stock. Outlined below are key reports that provide context for Standard Biotools Stock:Standard Biotools has a market cap of 357.84 M, operating margin of -29.42%, ROE of -13.13%. Use Correlation Analysis to explore allocation context. This includes a position in Standard Biotools within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.Analysis related to Standard Biotools should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Earnings Share -0.15 | Revenue Per Share | Quarterly Revenue Growth -0.14 | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than book value, which reflects Standard accounting equity. Standard Biotools' market capitalization is 357.84 M. A P/B ratio of 0.88 suggests Standard Biotools trades near or below book value. Enterprise value stands at 217.59 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Standard Biotools' intrinsic value and market price are different measures derived from different inputs. For Standard Biotools, key inputs include a P/B ratio of 0.88, a profit margin of -87.77%, ROE of -13.13%, and revenue of 85.33 M. By contrast, market price reflects the level where buyers and sellers transact.